About this Journal Submit a Manuscript Table of Contents
Stroke Research and Treatment
Volume 2014 (2014), Article ID 651921, 6 pages
http://dx.doi.org/10.1155/2014/651921
Research Article

Co-Occurrence of Arthritis and Stroke amongst Middle-Aged and Older Adults in Canada

School of Kinesiology and Health Science, York University, Toronto, ON, Canada M3J 1P3

Received 10 December 2013; Revised 18 March 2014; Accepted 1 April 2014; Published 16 April 2014

Academic Editor: Chelsea Kidwell

Copyright © 2014 Roman Matveev and Chris I. Ardern. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Mortality, Summary List of Causes, Statistics Canada, 2009, http://www.statcan.gc.ca/pub/84f0209x/84f0209x2008000-eng.pdf.
  2. M. J. O'Donnell, D. Xavier, L. Liu et al., “Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study,” The Lancet, vol. 376, no. 9735, pp. 112–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Lagacé, A. Perruccio, M. DesMeules, and E. Badley, “The impact of arthritis on canadians,” in Health Canada. Arthritis in Canada: An Ongoing Challenge, E. M. Badley and M. DesMeules, Eds., vol. 2, pp. 7–34, 2003. View at Google Scholar
  4. W. Zhang and A. H. Anis, “The economic burden of rheumatoid arthritis: beyond health care costs,” Clinical Rheumatology, vol. 30, supplement 1, pp. S25–S32, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. O'Donnell, C. Lagacé, L. McRae, and C. Bancej, “Life with arthritis in canada: a personal and public health challenge,” Chronic Diseases in Canada, vol. 31, no. 3, pp. 135–136, 2011. View at Google Scholar · View at Scopus
  6. L. Lévy, B. Fautrel, T. Barnetche, and T. Schaeverbeke, “Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature,” Clinical and Experimental Rheumatology, vol. 26, no. 4, pp. 673–679, 2008. View at Google Scholar · View at Scopus
  7. C. Meune, E. Touzé, L. Trinquart, and Y. Allanore, “High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis,” Archives of Cardiovascular Diseases, vol. 103, no. 4, pp. 253–261, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. A. McEntegart, H. A. Capell, D. Creran, A. Rumley, M. Woodward, and G. D. O. Lowe, “Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis,” Rheumatology, vol. 40, no. 6, pp. 640–644, 2001. View at Google Scholar · View at Scopus
  9. D. H. Solomon, E. W. Karlson, E. B. Rimm et al., “Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis,” Circulation, vol. 107, no. 9, pp. 1303–1307, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. C. D. Lee, A. R. Folsom, and S. N. Blair, “Physical activity and stroke risk: a meta-analysis,” Stroke, vol. 34, no. 10, pp. 2475–2481, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. Canadian Community Health Survey—Annual Component (CCHS), Statistics Canada, 2012, http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=3226.
  12. Tracking Heart Disease and Stroke in Canada. Public Health Agency of Canada, 2009, http://www.phac-aspc.gc.ca/publicat/2009/cvd-avc/pdf/cvd-avs-2009-eng.pdf.
  13. M. Hollander, P. J. Koudstaal, M. L. Bots, D. E. Grobbee, A. Hofman, and M. M. B. Breteler, “Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study,” Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 3, pp. 317–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Falcone and J. Y. Chong, “Gender differences in stroke among older adults,” Geriatrics and Aging, vol. 10, no. 8, pp. 497–500, 2007. View at Google Scholar · View at Scopus
  15. Z. Nadareishvili, K. Michaud, J. M. Hallenbeck, and F. Wolfe, “Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study,” Arthritis Care and Research, vol. 59, no. 8, pp. 1090–1096, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. D. H. Solomon, N. J. Goodson, J. N. Katz et al., “Patterns of cardiovascular risk in rheumatoid arthritis,” Annals of the Rheumatic Diseases, vol. 65, no. 12, pp. 1608–1612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. K. Bacani, S. E. Gabriel, C. S. Crowson, J. A. Heit, and E. L. Matteson, “Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?” Arthritis and Rheumatism, vol. 64, no. 1, pp. 53–61, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Lindhardsen, O. Ahlehoff, G. H. Gislason et al., “Risk of atrial fibrillation and stroke in rheumatoid arthritis: danish nationwide cohort study,” British Medical Journal, vol. 344, Article ID e1257, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Rincón, K. Williams, M. P. Stern, G. L. Freeman, D. H. O'Leary, and A. Escalantel, “Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects,” Arthritis and Rheumatism, vol. 48, no. 7, pp. 1833–1840, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. F. Wolfe and K. Michaud, “Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy,” American Journal of Medicine, vol. 116, no. 5, pp. 305–311, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Roumie, E. F. Mitchel, L. Kaltenbach, P. G. Arbogast, P. Gideon, and M. R. Griffin, “Nonaspirin NSAIDs, cyclooxygenase 2 inhibitors, and the risk for stroke,” Stroke, vol. 39, no. 7, pp. 2037–2045, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. C. F. Christiansen, S. Christensen, F. Mehnert, S. R. Cummings, R. D. Chapurlat, and H. T. Sørensen, “Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study,” Archives of Internal Medicine, vol. 169, no. 18, pp. 1677–1683, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C.-H. Chang, W.-Y. Shau, C.-W. Kuo, S.-T. Chen, and M.-S. Lai, “Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study,” Stroke, vol. 41, no. 9, pp. 1884–1890, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. Middle-age blood pressure changes affect lifetime heart disease, stroke risk, ScienceDaily, 2011, http://www.sciencedaily.com/releases/2011/12/111219203849.htm.
  25. R. L. Sacco, “Identifying patient populations at high risk for stroke,” Neurology, vol. 51, supplement 3, pp. S27–S30, 1998. View at Google Scholar · View at Scopus
  26. G. Hu, C. Sarti, P. Jousilahti, K. Silventoinen, N. C. Barengo, and J. Tuomilehto, “Leisure time, occupational, and commuting physical activity and the risk of stroke,” Stroke, vol. 36, no. 9, pp. 1994–1999, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Bolen, L. Murphy, K. Greenlund et al., “Arthritis as a potential barrier to physical activity among adults with heart disease—United States, 2005 and 2007,” Morbidity and Mortality Weekly Report, vol. 58, no. 7, pp. 165–169, 2009. View at Google Scholar
  28. T. Kurth, J. M. Gaziano, K. Berger et al., “Body mass index and the risk of stroke in men,” Archives of Internal Medicine, vol. 162, no. 22, pp. 2557–2562, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Chen, S.-Y. Chuang, H.-J. Chen, Y. E. H. Wen-Ting, and P. A. N. Wen-Harn, “Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a chinese cohort study,” Arthritis Care and Research, vol. 61, no. 2, pp. 225–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. J. Weir, S. W. Muir, M. R. Walters, and K. R. Lees, “Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke,” Stroke, vol. 34, no. 8, pp. 1951–1956, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. M.-C. Aubry, H. Maradit-Kremers, M. S. Reinalda, C. S. Crowson, W. D. Edwards, and S. E. Gabriel, “Differences in atherosclerotic coronary heart disease between subjects with and without rheumatoid arthritis,” Journal of Rheumatology, vol. 34, no. 5, pp. 937–942, 2007. View at Google Scholar · View at Scopus
  32. S. V. Ramagopalan, C. J. Wotton, A. E. Handel, D. Yeates, and M. J. Goldacre, “Risk of subarachnoid haemorrhage in people admitted to hospital with selected immune-mediated diseases: record-linkage studies,” BMC Neurology, vol. 13, no. 1, article 176, 2011. View at Google Scholar · View at Scopus
  33. K. A. Taubert, “Can patients with cardiovascular disease take nonsteroidal antiinflammatory drugs?” Circulation, vol. 117, no. 17, pp. e322–e324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Madhok, O. Wu, G. McKellar, and G. Singh, “Non-steroidal anti-inflammatory drugs—changes in prescribing may be warranted,” Rheumatology, vol. 45, no. 12, pp. 1458–1460, 2006. View at Publisher · View at Google Scholar · View at Scopus